Recently the University of Toledo published a review paper in ‘The current opinion in pharmacology’. In this review, the authors examine the past and current trends of kinase research and...Read More
The PamStation is at the core of PamGene’s technology. This fully automated instrument is designed for processing PamChip microarrays to measure kinase activity and can be found at universities worldwide....Read More
transMed is an integrated training network funded by the European Union to train the next generation of scientists in translational medicine. The consortium focuses on bench-to-bedside development of treatments for...Read More
“My work at PamGene has always been data driven,” tells Rik de Wijn, data scientist and PamGene’s head of diagnostic assay services. De Wijn joined Pamgene in 2002 after completing...Read More
PamGene International B.V., a biomarker services company focused on the development of blood-based immunotherapy selection tests, and Sanquin, the not-for-profit blood services provider in the Netherlands, today announced the extension...Read More
Meet PamGene at the 8th Drug Discovery Strategic Summit in Amsterdam (November 4 and 5). Our colleagues Tushar Tomar and Martijn Dankers would be happy to discuss how PamGene’s kinase...Read More
Today, PamGene International B.V., an in-vitro diagnostics company focused on the development and commercialization of blood-based immunotherapy selection tests, highlights eight publications in international journals that have confirmed that kinase-activity...Read More
PRECISE, a Dutch-Swiss consortium between PamGene International B.V., Novigenix SA and Radboud University Medical Center, has been awarded a Eurostars grant of up to €1 million to develop a novel...Read More
Kinases have been running like a thread through Dr. Julhash Uddin Kazi’s career. They also played the lead part in the Lund University’s Associate Professor of Molecular Medicine’s recent Nature...Read More
PamGene International B.V., an in-vitro diagnostics company focused on the development and commercialization of blood-based immunotherapy selection tests, today announced it has received extension of its ISO 13485:2016 certification. The...Read More
